BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 10082238)

  • 1. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat.
    Mos J; Mollet I; Tolboom JT; Waldinger MD; Olivier B
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):123-35. PubMed ID: 10082238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.
    Waldinger MD; van De Plas A; Pattij T; van Oorschot R; Coolen LM; Veening JG; Olivier B
    Psychopharmacology (Berl); 2002 Mar; 160(3):283-9. PubMed ID: 11889497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Montejo-González AL; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Ciudad J; Daniel E; De la Gandara J; Derecho J; Franco M; Gomez MJ; Macias JA; Martin T; Perez V; Sanchez JM; Sanchez S; Vicens E
    J Sex Marital Ther; 1997; 23(3):176-94. PubMed ID: 9292833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].
    Montejo AI; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Daniel E; de Dios A; de la Gándara J; Derecho J; Franco M; Gómez MJ; Macías JA; Martín T; Pérez V; Sánchez JM; Sánchez S; Vicens E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):311-21. PubMed ID: 9054202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
    de Jong TR; Snaphaan LJ; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):39-48. PubMed ID: 16107310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine chronic treatment inhibits male rat sexual behavior by affecting both copulatory behavior and the genital motor pattern of ejaculation.
    Hueletl-Soto ME; Carro-Juárez M; Rodríguez-Manzo G
    J Sex Med; 2012 Apr; 9(4):1015-26. PubMed ID: 21676185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Sánchez C; Meier E
    Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of selective serotonin reuptake inhibitors in premature ejaculation.
    Waldinger MD; Olivier B
    Curr Opin Investig Drugs; 2004 Jul; 5(7):743-7. PubMed ID: 15298071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.
    de Jong TR; Pattij T; Veening JG; Dederen PJ; Waldinger MD; Cools AR; Olivier B
    Neuroscience; 2005; 134(4):1351-61. PubMed ID: 16019152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
    Kim SC; Seo KK
    J Urol; 1998 Feb; 159(2):425-7. PubMed ID: 9649255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation.
    Moreland AJ; Makela EH
    Ann Pharmacother; 2005; 39(7-8):1296-301. PubMed ID: 15941821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tramadol: Effects on sexual behavior in male rats are mainly caused by its 5-HT reuptake blocking effects.
    Olivier JD; Esquivel Franco DC; Oosting R; Waldinger M; Sarnyai Z; Olivier B
    Neuropharmacology; 2017 Apr; 116():50-58. PubMed ID: 27890601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.